Login

Vection Technologies Ltd's software adapts existing CAD programs for real-time collaboration and visualization. 00:10:00

Share On Facebook Share On Twitter

Gianmarco Biagi is the CEO of Vection Technologies

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Transforming Healthcare: Innovating Incentives for Better Outcomes | Andrew Toy, CEO, Clover Health Investments Corp.
00:10:00
Key Highlights of Our Copper and Cobalt Project
00:10:00
Analyzing the Housing Market: Trends, Challenges, and Opportunities|CEO, American Realty Advisors
00:10:00
Believes that best ideas happen offline|Dave Morin,Managing Partner,Offline Ventures
00:10:00
Insights into Current Trends and Opportunities in the Global Mining Market
00:10:00
At Ormat's Investor & Analyst Day, CEO Doron Blachar highlighted the company's leadership in the U.S. geothermal power sector with its 772 MW portfolio.
00:10:00
2019 Fink Investing Conference: Keynote Conversation with Ric Kayne
00:10:00
Optimal Timing for Roth Conversions and Tax Savings | Craig Cairns - PRESIDENT of Howe & Rusling, Inc.
00:10:00
Contra Guys – Benj’s Stock Picks – 2021 Year in Review & Outlook | Contra the Heard Investment Letter
00:10:00
Ariel Investments' Vlad Byalik on Favorable Picks in Korean Banking and Philippine Real Estate Stocks
00:10:00
Perspectives from Activist Investor Bill Ackman
00:10:00
Sustainability in Investment Portfolios: Key Insights from Allianz Global Investors | Tobias C. Pross, CEO , Allianz Global Investors.

© 2026 Nehu